Beta Drugs Limited

• Beta Drugs Q2 Results FY27: PAT Jumps 51.8% to Rs 18.55 Cr, Revenue Rs 137.49 Cr
  Univest · 22 Oct 2026
• Beta Drugs Reports Q2 Consolidated Net Profit of ₹19.3 Crore on Revenue of ₹137 Crore
  Sahi · 22 Oct 2026
• Beta Drugs NSE:BETA Q2 FY27 Results Board Meeting Outcome
  Kalkine India · 22 Oct 2026
• Lab-designed molecule reduces amyloid beta, the protein linked to Alzheimer's disease, in mice
  Medical Xpress · 17 Oct 2026
• Beta Drugs vs Dishman Carbogen Amcis vs Fredun Pharmaceuticals
  Univest · 16 Oct 2026
• Beta Drugs Share Price gains as fundamentals stay strong
  Univest · 15 Oct 2026
• Beta Drugs (NSE:BETA) Ticks All The Boxes When It Comes To Earnings Growth
  Simply Wall Street · 14 Oct 2026
• Beta Drugs Stock Analysis and Key Price Levels
  Kalkine India · 09 Oct 2026
• Beta Drugs (NSE:BETA): What Does the Q2 FY27 Demat Confirmation Certificate Mean?
  Kalkine India · 06 Oct 2026
• Beta (BETA.NS) Stock Analysis: Flat at ₹2055.00, What's Next 2026-10-02 - Put Flow Alert
  https://www.siam.in/ · 02 Oct 2026
• Beta Drugs NSE:BETA Trading Window Closure October 2026
  Kalkine India · 30 Sep 2026
• Beta Drugs: Best Stock in Its Sector? Key Metrics
  Univest · 24 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →